Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Disease × TIC10 compound × Clear all

Sponsor

Conditions

Triple Negative Breast Neoplasms 2 Neoplasm Metastasis 2 Neuroendocrine Tumors 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Glioma 1 Glioblastoma 1 Endometrial Neoplasms 1 Endometrial Cancer Recurrent 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Breast Neoplasms, Male 1

Interventions

fluciclovine F-18 2 Positron-Emission Tomography 2 Injections 2 ioflupane 1 aflibercept 1 Water 1 Methylene Blue 1 Mammography 1 Drug Delivery Systems 1 Diagnosis, Computer-Assisted 1 Daunorubicin 1 Cytarabine 1 Control Groups 1 CPX-351 1 4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 1 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡